Ruptured Aneurysm Clinical Trial
Official title:
Ruptured Aneurysms Treated With Hydrogel Coils
To determine safety and occlusion rates when second-generation hydrogel coils are used in the treatment of ruptured intracranial aneurysms.
RAGE is a prospective, non-randomized, multicenter, post-market study. The RAGE study is designed to determine the safety and occlusion rates of hydrogel coils in the ruptured aneurysm study population. Secondary objectives include determining clinical outcomes, packing density, occlusion stability, rates of recurrence, rebleed, retreatment, and adverse events. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04391803 -
EvaLuate EndoVascular Treatment of Acutely Ruptured Shallow Intradural Aneurysms With the Pipeline™ Flex Embolization Device With Shield TEchnology™ (ELEVATE)
|
N/A | |
| Terminated |
NCT02864940 -
Memory Training in Aneurysmal Subarachnoid Hemorrhage Patients
|
N/A | |
| Active, not recruiting |
NCT03408379 -
Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN
|
||
| Recruiting |
NCT04499508 -
Appraising the Embolization of Aneurysms Using Balt Optima™ Coil System (APPLY Study)
|
N/A |